Video Latest - ecancer

What are CDKs?

Dr Ghadeer Shubassi - FIRC Institute of Molecular Oncology (IFOM), Milan, Italy

26 Oct 2016

Biomarkers of sensitivity and resistance

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

26 Oct 2016

Editor's ESMO 2016 roundup

Prof Gordon McVie - Editor in Chief, ecancer

24 Oct 2016

Abiraterone in patients with recurrent epithelial ovarian cancer

Dr Susanna Banerjee - The Royal Marsden, London, UK

24 Oct 2016

Fatigue in men with castration resistant prostate cancer treated with enzalutamide

Dr Simon Chowdhury - Guy's Hospital, London, UK

21 Oct 2016

PDL-1 assay concordance

Dr Jill Walker - AstraZeneca, UK

20 Oct 2016

First evidence of significant clinical activity of PD1 inhibition in metastatic prostate cancer

Dr Julie Graff - Knight Cancer Institute, Oregon Health & Science University, Portland, USA

17 Oct 2016

CDK4/6 inhibitors for metastatic breast cancer

Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy

14 Oct 2016

TRAIL induced apoptosis for cancer stem cells

Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt

12 Oct 2016

Who should receive combination therapy for ER positive breast cancer?

Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

12 Oct 2016

Positive lessons of negative trials

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

12 Oct 2016

Drug repurposing of propranolol

Dr Pan Pantziarka - Anticancer Fund, UK

12 Oct 2016

Video